PODCAST: China Sets Goals for 2024, and a French Snub for Chinese EVs

By Doug Young & Rene Vanguestaine

Chinese leaders said they’ll prioritize progress and stability in 2024 at their annual Central Economic Work Conference. Does that mean they’ll put greater emphasis on the economy? And France and Turkey take new steps that could limit Chinese EV imports. What’s behind this growing bias against Chinese electric cars that are flooding the global market?

About China Inc

China Inc by Bamboo Works discusses the latest developments on Chinese companies listed in Hong Kong and the United States to drive informed decision-making for investors and others interested in this dynamic group of companies.

Subscribe to China Inc on your favorite app:

Apple Podcasts Spotify Google Podcasts

,
, , ,

Related Articles

RELATED ARTICLES

  1. Illustration of a Chinese engineer who ensures an egine's output and stability.
    CHINA BULLETIN: Progress First, Stability Second, Says Politburo
  2. PODCAST: The EU investigates Chinese EVs, and foreign investors flee China
  3. CHINA BULLETIN: Weak Inflation, Producer Price Data Hint at Flagging Rebound
  4. PODCAST: China EVs Under Attack, and Alibaba’s Sputtering Split-up
  5. CHINA BULLETIN: China-U.S. Rapprochement Continues with Xi-Biden Call, Yellen Visit
  6. Henderson Land gets $7.7 billion helping hand in drive to become new ‘King of Central’
    0012.HK
  7. PODCAST: US Targets China EVs, and the Passing of a Beverage Tycoon
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo File-alt

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

Recent Articles

The loss-making developer of cancer immunotherapies raised just enough financing last year to cross the valuation threshold for a Hong Kong listing.

Sunho Biologics gets green light for downsized IPO

The loss-making developer of cancer immunotherapies raised just enough financing last year to cross the valuation threshold for a Hong Kong listing Key Takeaways: Sunho Biologics has no revenue or…